Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 11, 2009
Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among neutropenic patients in the United States
Amy K O'Sullivan, Ankur Pandya, George Papadopoulos, et al.
Cellular Microbiology
|
June 1, 2012
Cryptococcus neoformans phospholipase B1 activates host cell Rac1 for traversal across the blood-brain barrier
Ravi Maruvada, Longkun Zhu, Donna Pearce, et al.
Frontiers in Cellular and Infection Microbiology
|
June 6, 2024
<i>Cryptococcus neoformans</i> trehalose-6-phosphate synthase (tps1) promotes organ-specific virulence and fungal protection against multiple lines of host defenses
Kristie Goughenour, Arianna Creech, Jintao Xu, et al.
Open Forum Infectious Diseases
|
July 24, 2024
Clinical Mycology Today: Emerging Challenges and Opportunities
Jessica Little, Adriana M Rauseo, Julio C Zuniga-Moya, et al.
Mycoses
|
June 16, 2021
ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries
Shivaprakash M Rudramurthy, Martin Hoenigl, Jacques F Meis, et al.
Pharmacotherapy
|
October 4, 2012
Cost of invasive fungal infections in the era of new diagnostics and expanded treatment options
Elizabeth Dodds Ashley, Richard Drew, Melissa Johnson, et al.
The New England Journal of Medicine
|
December 20, 2002
Comparison of caspofungin and amphotericin B for invasive candidiasis
Jorge Mora-Duarte, Robert Betts, Coleman Rotstein, et al.
Antimicrobial Agents and Chemotherapy
|
February 25, 2005
Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis
Robert A Larsen, Peter G Pappas, John Perfect, et al.
Mycopathologia
|
January 8, 2025
Advancing Patient Advocacy in Mycology: Cultivating Collaboration in Education, Research, and Policy
Rob Purdie, Rasha Kuran, Ana Alastruey-Izquierdo, et al.
Open Forum Infectious Diseases
|
December 3, 2020
Occult <i>Talaromyces marneffei</i> Infection Unveiled by the Novel Mp1p Antigen Detection Assay
Vo Trieu Ly, Nguyen Tat Thanh, Nguyen Thi Mai Thu, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 11, 2009
Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among neutropenic patients in the United States
Amy K O'Sullivan, Ankur Pandya, George Papadopoulos, et al.
Cellular Microbiology
|
June 1, 2012
Cryptococcus neoformans phospholipase B1 activates host cell Rac1 for traversal across the blood-brain barrier
Ravi Maruvada, Longkun Zhu, Donna Pearce, et al.
Frontiers in Cellular and Infection Microbiology
|
June 6, 2024
<i>Cryptococcus neoformans</i> trehalose-6-phosphate synthase (tps1) promotes organ-specific virulence and fungal protection against multiple lines of host defenses
Kristie Goughenour, Arianna Creech, Jintao Xu, et al.
Open Forum Infectious Diseases
|
July 24, 2024
Clinical Mycology Today: Emerging Challenges and Opportunities
Jessica Little, Adriana M Rauseo, Julio C Zuniga-Moya, et al.
Mycoses
|
June 16, 2021
ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries
Shivaprakash M Rudramurthy, Martin Hoenigl, Jacques F Meis, et al.
Pharmacotherapy
|
October 4, 2012
Cost of invasive fungal infections in the era of new diagnostics and expanded treatment options
Elizabeth Dodds Ashley, Richard Drew, Melissa Johnson, et al.
The New England Journal of Medicine
|
December 20, 2002
Comparison of caspofungin and amphotericin B for invasive candidiasis
Jorge Mora-Duarte, Robert Betts, Coleman Rotstein, et al.
Antimicrobial Agents and Chemotherapy
|
February 25, 2005
Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis
Robert A Larsen, Peter G Pappas, John Perfect, et al.
Mycopathologia
|
January 8, 2025
Advancing Patient Advocacy in Mycology: Cultivating Collaboration in Education, Research, and Policy
Rob Purdie, Rasha Kuran, Ana Alastruey-Izquierdo, et al.
Open Forum Infectious Diseases
|
December 3, 2020
Occult <i>Talaromyces marneffei</i> Infection Unveiled by the Novel Mp1p Antigen Detection Assay
Vo Trieu Ly, Nguyen Tat Thanh, Nguyen Thi Mai Thu, et al.
Page
of 5